Physician profile
Beverly Demchuk
NPI 1932292554
$12,378.88
in general payments reported to CMS, 2019-2025
47 companies · $1,766 in 2025
The $1,766 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,158 · 2020: $1,514 · 2021: $2,184 · 2022: $1,690 · 2023: $1,276 · 2024: $1,791 · 2025: $1,766.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,833.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,833.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,057.95 | 2019-2025 | Farxiga, Wainua |
| Abbott Laboratories | $1,267.33 | 2019-2025 | Mitraclip, Aveir |
| Abiomed | $1,124.90 | 2019-2025 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,072.03 | 2019-2025 | Jardiance |
| Esperion Therapeutics, INC. | $732.20 | 2020-2023 | Nexletol |
| Novartis Pharmaceuticals Corporation | $543.74 | 2019-2025 | |
| Kestra Medical Technology Services, INC. | $481.44 | 2023-2025 | Assure Wcd |
| Boston Scientific Corporation | $463.57 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, Varithena Administration Pack, Watchman Flx |
| Amgen INC. | $456.02 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $432.79 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $428.15 | 2020-2025 | Camzyos, Eliquis |
| Biotronik INC. | $299.29 | 2021-2025 | Biomonitor |
| Pfizer INC. | $284.03 | 2019-2025 | |
| Medtronic, INC. | $260.46 | 2022 | |
| Shockwave Medical, INC | $235.87 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $182.32 | 2021-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Novo Nordisk INC | $170.88 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Chiesi USA, INC. | $168.72 | 2019-2025 | Kengreal |
| Cardiovascular Systems INC. | $166.95 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $160.44 | 2019-2025 | Amvuttra, Onpattro |
| Sanofi-Aventis U.S. LLC | $147.42 | 2019-2024 | |
| Kowa Pharmaceuticals America, INC. | $143.68 | 2019-2022 | |
| Scpharmaceuticals INC. | $139.69 | 2024-2025 | |
| Arbor Pharmaceuticals, INC. | $110.93 | 2020-2021 | |
| Heartflow, INC. | $102.65 | 2024-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $100.33 | 2024 | Arcalyst |
| Angiodynamics, INC. | $73.63 | 2020-2023 | Auryon Laser System 100-120 Vac |
| Merck Sharp & Dohme LLC | $64.62 | 2021-2024 | Verquvo |
| Saranas, INC. | $57.52 | 2021 | |
| Irhythm Technologies, INC. | $38.73 | 2020 | |
| Atricure, INC. | $36.44 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $34.63 | 2019-2024 | Evkeeza |
| Kiniksa Pharmaceuticals, LTD. | $33.37 | 2023 | Arcalyst |
| Lundbeck LLC | $33.28 | 2019-2021 | |
| Cvrx, INC. | $32.58 | 2024 | Barostim Neo System |
| Impulse Dynamics (USA) INC. | $32.32 | 2024 | Optimizer |
| Portola Pharmaceuticals, LLC | $29.15 | 2020 | |
| Daiichi Sankyo INC. | $26.12 | 2020-2023 | Injectafer |
| Cardinal Health 200 LLC | $24.82 | 2019 | |
| Bard Peripheral Vascular, INC. | $18.44 | 2022 | |
| Cordis US Corp. | $18.13 | 2023 | Brite Tip Radianz |
| Philips North America LLC | $17.52 | 2024 | (5044) Mcot |
| Glaxosmithkline, LLC. | $15.63 | 2024 | Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $15.11 | 2025 | |
| Akcea Therapeutics, INC. | $14.63 | 2019 | |
| Alexion Pharmaceuticals, INC. | $14.22 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $14.21 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beverly Demchuk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.